JP2009521908A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521908A5
JP2009521908A5 JP2008547861A JP2008547861A JP2009521908A5 JP 2009521908 A5 JP2009521908 A5 JP 2009521908A5 JP 2008547861 A JP2008547861 A JP 2008547861A JP 2008547861 A JP2008547861 A JP 2008547861A JP 2009521908 A5 JP2009521908 A5 JP 2009521908A5
Authority
JP
Japan
Prior art keywords
seq
peptide
nucleic acid
cargo molecule
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008547861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521908A (ja
JP5264502B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/010271 external-priority patent/WO2007076904A1/en
Publication of JP2009521908A publication Critical patent/JP2009521908A/ja
Publication of JP2009521908A5 publication Critical patent/JP2009521908A5/ja
Application granted granted Critical
Publication of JP5264502B2 publication Critical patent/JP5264502B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008547861A 2005-12-30 2006-10-25 細胞透過性ペプチドとして使用できるペプチド Expired - Fee Related JP5264502B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05028755 2005-12-30
EP05028755.6 2005-12-30
PCT/EP2006/010271 WO2007076904A1 (en) 2005-12-30 2006-10-25 Peptides useful as cell-penetrating peptides

Publications (3)

Publication Number Publication Date
JP2009521908A JP2009521908A (ja) 2009-06-11
JP2009521908A5 true JP2009521908A5 (https=) 2011-06-30
JP5264502B2 JP5264502B2 (ja) 2013-08-14

Family

ID=37491778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008547861A Expired - Fee Related JP5264502B2 (ja) 2005-12-30 2006-10-25 細胞透過性ペプチドとして使用できるペプチド

Country Status (16)

Country Link
US (3) US20100061932A1 (https=)
EP (1) EP1966240B3 (https=)
JP (1) JP5264502B2 (https=)
KR (1) KR101317100B1 (https=)
CN (1) CN101395180B (https=)
AT (1) ATE501169T1 (https=)
AU (1) AU2006332193B2 (https=)
BR (1) BRPI0620806B8 (https=)
CA (1) CA2646833C (https=)
DE (1) DE602006020617D1 (https=)
ES (1) ES2361621T7 (https=)
IL (1) IL192131A (https=)
MX (1) MX2008008548A (https=)
PL (1) PL1966240T6 (https=)
SI (1) SI1966240T1 (https=)
WO (1) WO2007076904A1 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005051366A1 (de) 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
EP2050461A1 (en) * 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2090584A1 (en) * 2008-02-13 2009-08-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Identification of a novel cysteine-rich cell penetrating peptide
CA2716565C (en) * 2008-02-28 2017-09-12 Toray Industries, Inc. Pharmaceutical composition for transnasal administration
WO2011005540A1 (en) 2009-06-22 2011-01-13 Burnham Institute For Medical Research Methods and compositions using peptides and proteins with c-terminal elements
JP5818319B2 (ja) * 2009-12-14 2015-11-18 国立大学法人北海道大学 脂質膜構造体に細胞透過能を付与および/または脂質膜構造体の細胞透過能を増強するペプチド、ならびにそれらペプチドと結合した脂質を構成脂質として含む、細胞透過能を有するまたは細胞透過能が増強された脂質膜構造体
WO2011084061A1 (en) 2010-01-08 2011-07-14 Universitair Medisch Centrum St. Radboud Cpp (cell penetrating peptide) and its uses
FR2955773B1 (fr) * 2010-02-01 2017-05-26 Commissariat Energie Atomique Complexe moleculaire de ciblage des antigenes vers les cellules presentatrices d'antigene et ses applications pour la vaccination
MX348337B (es) * 2010-11-26 2017-06-07 Evonik Roehm Gmbh Peptido derivado de lactoferrina humana para usarse como agente de enmascaramiento de antigenos.
CN102174078A (zh) * 2011-01-10 2011-09-07 中国药科大学 肿瘤细胞选择性穿膜肽的应用
CN102091036A (zh) * 2011-01-10 2011-06-15 中国药科大学 一种含有抗肿瘤药物的复合脂质体及其制备方法和用途
CN102153629B (zh) * 2011-01-20 2013-07-24 华中科技大学 一种短肽及其应用
WO2012118778A1 (en) 2011-02-28 2012-09-07 Sanford-Burnham Medical Research Institute Truncated car peptides and methods and compositions using truncated car peptides
AU2012262488A1 (en) 2011-05-31 2014-01-16 Airware, Inc. Re-calibration of AB NDIR gas sensors
US10179801B2 (en) 2011-08-26 2019-01-15 Sanford-Burnham Medical Research Institute Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
CN102988295B (zh) * 2011-09-09 2015-07-29 复旦大学 一种穿膜肽修饰的纳米粒及其制备方法
CN102993296A (zh) * 2011-09-14 2013-03-27 广州格拉姆生物科技有限公司 牛乳铁蛋白肽及其制备方法
US12083158B2 (en) 2011-10-07 2024-09-10 Morehouse School Of Medicine Antibacterial compositions, methods of making and use thereof
WO2013052058A1 (en) * 2011-10-07 2013-04-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
US8669226B2 (en) 2011-10-07 2014-03-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
DE102011055229A1 (de) 2011-11-10 2013-05-16 Evonik Degussa Gmbh Verfahren zur Bereitstellung von Regelleistung mit einem Energiespeicher unter Ausnutzung von Toleranzen bei der Bestimmung der Frequenzabweichung
DE102011055231A1 (de) * 2011-11-10 2013-05-16 Evonik Industries Ag Verfahren zur Bereitstellung von Regelleistung
EP3375457B1 (en) 2011-11-24 2020-06-24 Positec Power Tools (Suzhou) Co., Ltd Peptide sequence design and use thereof for peptide-mediated sirna delivery
CN103169982B (zh) * 2011-12-23 2015-05-20 中国科学院上海药物研究所 生物活性肽修饰的纳米银及其制备方法和用途
CN103382217B (zh) * 2012-12-11 2015-05-27 任发政 穿膜肽和药物组合物及其制备方法和应用
WO2015023649A2 (en) * 2013-08-12 2015-02-19 3M Innovative Properties Company Peptides for enhancing transdermal delivery
WO2015075747A1 (en) * 2013-11-19 2015-05-28 Council Of Scientific And Industrial Research Cell-penetrating peptide for biomolecule delivery
BR112016013516A8 (pt) 2013-12-12 2020-05-19 Life Technologies Corp complexo de transfecção e seu uso para aumentar transporte de molécula de carga em células e para o tratamento de câncer e terapia gênica, bem como método in vitro para fornecer um poliânion a uma célula
CN103784406A (zh) * 2014-01-20 2014-05-14 同济大学 一种偶联穿膜肽和mmp酶切位点的纳米颗粒
EP3148515B1 (en) * 2014-05-28 2019-12-04 Evonik Degussa GmbH Nanoparticle
CN107207627B (zh) * 2015-02-27 2022-05-24 学校法人常翔学园 具有膜透过性肽链的多糖衍生物
KR101647804B1 (ko) * 2015-06-24 2016-08-11 한국과학기술연구원 신규 세포투과 펩타이드 및 이의 용도
CN108456254B (zh) * 2017-02-20 2021-06-01 中国科学院上海药物研究所 一种tcs-穿膜肽-肿瘤蛋白酶底物肽融合蛋白、其制备方法和用途
EP3628047A1 (en) 2017-05-02 2020-04-01 Sanford Burnham Prebys Medical Discovery Institute Tumor associated monocyte/macrophage binding peptide and methods of use thereof
CN108101966B (zh) * 2017-12-26 2020-10-27 暨南大学 基于细胞穿膜肽的氧化还原敏感多肽及其在疫苗载体中的应用
EP3790534B1 (en) 2018-05-08 2023-08-30 Evonik Operations GmbH Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide
CN111499759B (zh) * 2019-01-31 2022-12-20 上海科技大学 一种具有细胞穿膜性的锌指蛋白-乳铁蛋白融合蛋白质及其制备与应用
US12583888B2 (en) 2019-02-04 2026-03-24 University Of Tartu Bi-specific extracellular matrix binding peptides and methods of use thereof
CN110078834B (zh) * 2019-05-05 2021-07-30 华中科技大学 一种类短肽、辅助透膜剂及其应用
CN112426438B (zh) * 2019-11-14 2023-12-05 上海鑫湾生物科技有限公司 用于调控酸性环境免疫应答的组合物、其制备方法和用途
CN121774830A (zh) * 2020-03-27 2026-04-03 阿拉斯廷护肤品股份有限公司 与色素沉着有关的组合物和方法
CA3246538A1 (en) 2022-03-30 2023-10-05 Evonik Operations Gmbh Formulations composed of cationic lipids and poly(lactic-co-glycolic acid) for the administration of polynucleotides into cells
JP2025535128A (ja) * 2022-10-13 2025-10-22 スティッチング ラドバウド ウニヴェルシテール メディシュ セントルム カーゴ及びインテレクチン1に結合する標的化部分を含む複合体
JP2025540052A (ja) 2022-12-01 2025-12-11 イェール ユニバーシティー 細胞内ペイロード送達用刺激応答性トレースレス操作プラットフォーム

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
ES2259800T3 (es) 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JP3207535B2 (ja) * 1992-08-07 2001-09-10 森永乳業株式会社 抗酸化剤
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
DE59708838D1 (de) 1996-08-30 2003-01-09 Jens Peter Fuerste Spiegelselektion und spiegelevolution von nucleinsäuren
US5989912A (en) 1996-11-21 1999-11-23 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
US5849902A (en) 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
DE19742706B4 (de) 1997-09-26 2013-07-25 Pieris Proteolab Ag Lipocalinmuteine
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
WO2000004132A1 (en) * 1998-07-15 2000-01-27 Samyang Genex Corporation Mass production method of lactoferrin polypeptide from yeast and useful microorganism thereof
JP3681982B2 (ja) * 1998-07-15 2005-08-10 サムヤン ジェネックス コーポレイション 酵母からラクトフェリンポリペプチドを大量生産する方法及びそれに有用な微生物菌株
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
ES2336887T5 (es) 2000-03-30 2019-03-06 Whitehead Inst Biomedical Res Mediadores de interferencia por ARN específicos de secuencias de ARN

Similar Documents

Publication Publication Date Title
JP2009521908A5 (https=)
Zhang et al. Recent advances of cell-penetrating peptides and their application as vectors for delivery of peptide and protein-based cargo molecules
Ziegler et al. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis
JP6077543B2 (ja) ペプチド
KR101317100B1 (ko) 세포-침투성 펩티드로서 유용한 펩티드
Zhang et al. Instructive design of triblock peptide amphiphiles for structurally complex micelle fabrication
KR20180064534A (ko) 조건부 활성 폴리펩티드
CN104736181A (zh) 包含靶向聚氨基酸与脂肪酸之缀合物的药物递送载剂
WO2008039483A3 (en) Modified self-assembling peptides
EP2574623A3 (en) Peptide vaccines for cancers expressing tumor-associated antigens
JP2014504150A5 (https=)
Hou et al. Co-delivery of siPTPN13 and siNOX4 via (myo) fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy
WO2014076655A1 (en) Polypeptides for blood brain barrier transport
EP2747786A2 (en) Pathogen and substance traps
KR101647804B1 (ko) 신규 세포투과 펩타이드 및 이의 용도
JP2015522264A5 (https=)
JP2022502347A (ja) 細胞透過性ペプチド
Platt et al. Stapling mimics noncovalent interactions of γ-carboxyglutamates in conantokins, peptidic antagonists of N-methyl-D-aspartic acid receptors
Li et al. Interaction of peptides with cell membranes: insights from molecular modeling
WO2018106273A1 (en) Collagen targeting nanofibers and nanosheets
JP2025028940A (ja) 界面活性ペプチドナノ構造および薬物送達における使用
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
F Nahhas et al. Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics
CN115243699A (zh) 分子导向系统肽及其用途
US20170304389A1 (en) Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan Sulfate Mediated Macropinocytosis